322 related articles for article (PubMed ID: 1855224)
21. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
22. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
[TBL] [Abstract][Full Text] [Related]
23. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
24. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
[TBL] [Abstract][Full Text] [Related]
25. p53 and K-RAS alterations in pancreatic epithelial cell lesions.
Kalthoff H; Schmiegel W; Roeder C; Kasche D; Schmidt A; Lauer G; Thiele HG; Honold G; Pantel K; Riethmüller G
Oncogene; 1993 Feb; 8(2):289-98. PubMed ID: 8426738
[TBL] [Abstract][Full Text] [Related]
26. p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Metcalf RA; Welsh JA; Bennett WP; Seddon MB; Lehman TA; Pelin K; Linnainmaa K; Tammilehto L; Mattson K; Gerwin BI
Cancer Res; 1992 May; 52(9):2610-5. PubMed ID: 1568228
[TBL] [Abstract][Full Text] [Related]
27. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
28. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L
Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651
[TBL] [Abstract][Full Text] [Related]
29. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
Fu XY; Bin XN; Tan M
Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
[TBL] [Abstract][Full Text] [Related]
30. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
[TBL] [Abstract][Full Text] [Related]
31. p53, erbB-2 and K-ras gene alterations are rare in spontaneous and plutonium-239-induced canine lung neoplasia.
Tierney LA; Hahn FF; Lechner JF
Radiat Res; 1996 Feb; 145(2):181-7. PubMed ID: 8606928
[TBL] [Abstract][Full Text] [Related]
32. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
[TBL] [Abstract][Full Text] [Related]
33. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.
Bodner SM; Minna JD; Jensen SM; D'Amico D; Carbone D; Mitsudomi T; Fedorko J; Buchhagen DL; Nau MM; Gazdar AF
Oncogene; 1992 Apr; 7(4):743-9. PubMed ID: 1565469
[TBL] [Abstract][Full Text] [Related]
34. [Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance].
Mitsudomi T; Oyama T; Gazdar AF; Minna JD; Okabayashi K; Shirakusa T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):944-7. PubMed ID: 1361656
[TBL] [Abstract][Full Text] [Related]
35. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.
Takahashi T; Takahashi T; Suzuki H; Hida T; Sekido Y; Ariyoshi Y; Ueda R
Oncogene; 1991 Oct; 6(10):1775-8. PubMed ID: 1656362
[TBL] [Abstract][Full Text] [Related]
36. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
Yehiely F; Oren M
Cell Growth Differ; 1992 Nov; 3(11):803-9. PubMed ID: 1467307
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.
Kitagawa Y; Wong F; Lo P; Elliott M; Verburgt LM; Hogg JC; Daya M
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):45-54. PubMed ID: 8679221
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of oncogenes and suppressor genes in lung cancer and bronchial lesions from high risk group].
Awaya Y; Hiyama K; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():39-41. PubMed ID: 1306237
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation.
Han KA; Kulesz-Martin MF
Cancer Res; 1992 Feb; 52(3):749-53. PubMed ID: 1370652
[TBL] [Abstract][Full Text] [Related]
40. Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants.
Nelson E
Crit Rev Toxicol; 1996 Sep; 26(5):483-549. PubMed ID: 8891429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
